Pills-drugs-stevecuk-Fotalia

Summit stops development of utrophin drug

We are disappointed to hear that Summit Therapeutics has decided to discontinue the development of its utrophin modulator, ezutromid.

Read more
Keep in touch
X
- Enter Your Location -
- or -